SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-023183
Filing Date
2024-02-29
Accepted
2024-02-29 16:38:12
Documents
107
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fdmt-20231231.htm   iXBRL 10-K 3131080
2 EX-10.14 fdmt-ex10_14.htm EX-10.14 26144
3 EX-10.15 fdmt-ex10_15.htm EX-10.15 107505
4 EX-10.16 fdmt-ex10_16.htm EX-10.16 107686
5 EX-10.17 fdmt-ex10_17.htm EX-10.17 105552
6 EX-23.1 fdmt-ex23_1.htm EX-23.1 2062
7 EX-31.1 fdmt-ex31_1.htm EX-31.1 19221
8 EX-31.2 fdmt-ex31_2.htm EX-31.2 19145
9 EX-32.1 fdmt-ex32_1.htm EX-32.1 11412
10 EX-97 fdmt-ex97.htm EX-97 60321
11 GRAPHIC img228980646_0.jpg GRAPHIC 110618
12 GRAPHIC img228980646_1.jpg GRAPHIC 70478
13 GRAPHIC img228980646_2.jpg GRAPHIC 87107
  Complete submission text file 0000950170-24-023183.txt   13672280

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fdmt-20231231.xsd EX-101.SCH 1955039
109 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-20231231_htm.xml XML 2044451
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39782 | Film No.: 24704477
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)